Acetazolamide


Curated chemical-disease associations from CTD
Disease IDDisease nameReference
MESH:D000014 Abnormalities, Drug-Induced PMID:16298872
MESH:D000138 Acidosis PMID:10221197; PMID:16772765; PMID:17536990; PMID:2016806; PMID:2109942; PMID:3769383; PMID:6065848; PMID:848601
MESH:D000532 Altitude Sickness PMID:2712085; PMID:6349608
MESH:D000741 Anemia, Aplastic PMID:2280240; PMID:4021656; PMID:448845; PMID:5481545; PMID:7393540
MESH:D000855 Anorexia PMID:6391074
MESH:D001002 Anuria PMID:634875
MESH:D001049 Apnea PMID:2712085
MESH:D001068 Feeding and Eating Disorders PMID:2712085
MESH:D001259 Ataxia PMID:17575025
MESH:D001284 Atrophy PMID:721694
MESH:D001744 Urinary Bladder Calculi PMID:6542938
MESH:D001926 Brain Death PMID:17536990
MESH:D001929 Brain Edema PMID:17536990
MESH:D002524 Cerebellar Ataxia PMID:10221197
MESH:D003072 Cognition Disorders PMID:19689182
MESH:D003128 Coma PMID:6065848
MESH:D003221 Confusion PMID:10221197; PMID:3769383
MESH:D003693 Delirium PMID:848601
MESH:D003875 Drug Eruptions PMID:11792017
MESH:D003967 Diarrhea PMID:8434677
MESH:D004240 Diverticulum PMID:6542938
MESH:D004408 Dysgeusia PMID:19689182
MESH:D004620 Embolism, Fat PMID:17536990
MESH:D005221 Fatigue PMID:11985388; PMID:2712085; PMID:3769383; PMID:8434677
MESH:D005862 Gerstmann Syndrome PMID:10692744
MESH:D006261 Headache PMID:19438913
MESH:D006345 Heart Septal Defects, Ventricular PMID:16298872
MESH:D006417 Hematuria PMID:6658117
MESH:D006940 Hyperemia PMID:15296063
MESH:D006965 Hyperplasia PMID:6520738; PMID:6542938
MESH:D006984 Hypertrophy PMID:721694
MESH:D006985 Hyperventilation PMID:2109942
MESH:D007008 Hypokalemia PMID:7031501
MESH:D007172 Erectile Dysfunction PMID:3566023
MESH:D007249 Inflammation PMID:6520738
MESH:D007669 Kidney Calculi PMID:10474731; PMID:1235390; PMID:1622512; PMID:2122276; PMID:3433023; PMID:8170551
MESH:D008569 Memory Disorders PMID:11985388
MESH:D008881 Migraine Disorders PMID:15613201; PMID:19438913
MESH:D009325 Nausea PMID:2712085
MESH:D009397 Nephrocalcinosis PMID:10207925; PMID:11096312; PMID:1622512; PMID:5353483; PMID:7950830
MESH:D009461 Neurologic Manifestations PMID:1462998; PMID:15772552
MESH:D010149 Pain, Postoperative PMID:14508327
MESH:D010198 Pancytopenia PMID:5395427
MESH:D010292 Paresthesia PMID:10915127; PMID:11985388; PMID:1978045; PMID:6349608; PMID:6391074
MESH:D011559 Pseudotumor Cerebri PMID:11824142
MESH:D011782 Quadriplegia PMID:835937
MESH:D012131 Respiratory Insufficiency PMID:2712085
MESH:D012393 Rosacea PMID:8251374
MESH:D012640 Seizures PMID:3607518
MESH:D012893 Sleep Wake Disorders PMID:2712085; PMID:8434677
MESH:D013262 Stevens-Johnson Syndrome PMID:25811541
MESH:D013651 Taste Disorders PMID:1978045; PMID:6391074
MESH:D014514 Ureteral Calculi PMID:6542938
MESH:D014517 Ureteral Obstruction PMID:5071712; PMID:634875
MESH:D014545 Urinary Calculi PMID:4706085
MESH:D014549 Urinary Incontinence PMID:3769383
MESH:D014570 Urologic Diseases PMID:6520738
MESH:D014581 Urticaria PMID:11792017
MESH:D014715 Vertebrobasilar Insufficiency PMID:9367331
MESH:D015431 Weight Loss PMID:8434677
MESH:D015746 Abdominal Pain PMID:8434677
MESH:D016857 Hypocapnia PMID:17536990
MESH:D017202 Myocardial Ischemia PMID:9529283
MESH:D018908 Muscle Weakness PMID:12322805
MESH:D019586 Intracranial Hypertension PMID:2320196
MESH:D020225 Sagittal Sinus Thrombosis PMID:6844972
MESH:D020514 Hypokalemic Periodic Paralysis PMID:7031501
MESH:D022124 Hyperammonemia PMID:17575025
MESH:D052878 Urolithiasis PMID:5071712; PMID:6520738; PMID:713211
MESH:D053040 Nephrolithiasis PMID:15455790; PMID:2016806; PMID:4191454; PMID:5353483
MESH:D053565 Hypercalciuria PMID:1622512
MESH:D053609 Lethargy PMID:3769383
MESH:D056486 Chemical and Drug Induced Liver Injury PMID:33814510
MESH:D056844 Renal Colic PMID:5071712
MESH:D058186 Acute Kidney Injury PMID:1124417; PMID:2655449; PMID:634875; PMID:8447311; PMID:9154665; PMID:9780431

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.